Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Establish Gene Expression Models Predicting Survival of Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP

NCT00450385 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT00450385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Establish Gene Expression Models Predicting Survival of Diffuse Large B-Cell Lymphoma Patients Treated With R-CHOP
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Terminated
Start date
April 24, 2007
Completion date
May 31, 2016
Enrollment
57 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma